Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study
Key Points
Key points are not available for this paper at this time.
Abstract
ClinicalTrials.gov NCT01618526.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Effects of Arabinoxylan and Resistant Starch on Intestinal Microbiota and Short-Chain Fatty Acids in Subjects with Metabolic Syndrome: A Randomised Crossover Study | Synapse